Overview

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
The effects of stopping long-term (7 years) and short term (2 years) risedronate therapy on BMD (bone mineral density) and BTMs (bone turnover markers) will be summarized.
Phase:
Phase 3
Details
Lead Sponsor:
Warner Chilcott
Treatments:
Etidronic Acid
Risedronate Sodium
Risedronic Acid